The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Greenleaf Daniel E since year 2005.
The trader's CIK number is 1208492.
At the time of this reporting, Greenleaf Daniel E is the Chief Executive Officer of Bioscrip, Inc. .
(stock ticker symbol BIOS).
See this page for all insider trading activities at Bioscrip, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2007-02-16||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||17,500||.56||9,887|
|2007-02-14||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||2,500||.58||1,450|
|2006-04-04||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||10,000||.94||9,350|
|2006-03-31||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||10,000||.85||8,500|
|2005-12-14||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||10,000||.80||8,000|
|2005-12-09||VQPH||Vioquest Pharmaceuticals, Inc.||Buy||10,000||.80||8,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Greenleaf Daniel E (Chief Executive Officer of Bioscrip, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.